Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.
Raymond J. de Souza: Travel-happy Trudeau will be remembered for shunning Israel
- yesterday, 9:47 AM
- nationalpost.com
- 0

No comments